Clinical Trial Update: FMT to Eradicate Intestinal Colonization by Carbapenem-resistant Enterobacteriaceae [Phase 1, Phase 2]

View source ↗

Summary

This update covers a Phase 1/2 clinical trial evaluating fecal microbiota transplantation to eradicate intestinal colonization by carbapenem-resistant Enterobac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carbapenem-resistant Enterobacteriaceae Infection

Drugs mentioned

• Fecal microbiota transplant (fecal microbiota transplant)

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Enterobacteriaceae Infections, Multi-antibiotic Resistance | Phase 1, Phase 2 | Status: RECRUITING